ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MIR17HG: A Cancerogenic Long-Noncoding RNA in Different Cancers

Tan, Fangshun; Chen, Jinlan; Du, Zhuoying; Zhao, Fangnan; Liu, Yuling; Zhang, Qi; Yuan, Chengfu*china three gorges univ
Current Pharmaceutical Design2022DOI: 10.2174/1381612828666220310144500
5被引9阅读
引用收藏
分享

摘要

LncRNA MIR17HG, located at chromosome 13q31, plays an inevitable role in promoting tumor progressions, such as tumorigenesis, proliferation, and metastasis. Besides, lncRNA MIR17HG is rare due to its open reading frame (ORF), which can be translated to produce protein. By systematically retrieval, we summarized that MIR17HG is an emerging lncRNA that exhibits carcinogenically in osteosarcoma ( OS), glioma, cervical squamous cell carcinoma (CSCC), colorectal cancer (CRC), gastric cancer (GC), atypical teratoid rhabdoid tumors (ATRT). Furthermore, a high expression level of MIR17HG protein is also linked with meningioma. Additionally, MIR17HG polymorphisms in glioma, CRC, liver cancer (LC), breast cancer ( BC), head and neck squamous cell carcinoma (HNSCC), and multiple myeloma (MM) also have a large influence on cancer susceptibility, prognosis, and so on. Collectively, long non-coding RNA MIR17HG's tumor-stimulative role could be a promising therapeutic target. Besides, by investigating patients' MIR17HG single-nucleotide polymorphisms (SNPs), clinicians could also personalize the productive interventions in gene therapy or predict the diagnosis/prognosis precisely.

学科与关键词

关键词
Long non-coding RNAMIR17HGbiomarkertherapeutic molecular targetdiagnosisprognosiscancermolecular mechanism
相关
加载中…
  • MIR4435-2HG: A Tumor-associated Long Non-coding RNA
    Zhao, Fangnan; Liu, Yuling; Tan, Fangshun; Tang, Lu; Du, Zhuoying; Mou, Jie; Zhou, Gang*; Yuan, Chengfu*Current Pharmaceutical Design, 2022, 28(25): 2043-2051.被引 2
  • LncmiRHG-MIR100HG: A new budding star in cancer
    Wu, Yingnan; Wang, Zhenzhen; Yu, Shan; Liu, Dongzhe*; Sun, Litao*Frontiers in Oncology, 2022, 12: 997532.被引 6
  • Enabling factor for cancer hallmark acquisition: Small nucleolar RNA host gene 17
    Zhang, Ningzhi; Sun, Yuanyuan; Wang, Tuo; Xu, Xinyuan; Cao, Mengru*Frontiers in Oncology, 2022, 12: 974939.
查看全部 →

发表信息

论文状态
公开发表
期刊
Current Pharmaceutical Design
发表日期
2022
卷期
第 28 卷, 第 15 期
页码
1272-1281
DOI
10.2174/1381612828666220310144500
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81974528, 82174035, 81773959]; innovational group project of Hubei Province Natural Science Foundation in China [2021CFA015, 2020ZYYD016]; Health Commission of Hubei Province scientific research project in China [WJ2019H527]

作者

  • T

    Tan, Fangshun (第一作者)

    china three gorges univ

  • C

    Chen, Jinlan

    china three gorges univ

查看全部 7 位作者收起作者
  • D

    Du, Zhuoying

    china three gorges univ

  • Z

    Zhao, Fangnan

    china three gorges univ

  • L

    Liu, Yuling

    china three gorges univ

  • Z

    Zhang, Qi

    china three gorges univ

  • Y

    Yuan, Chengfu (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417